Respiratory Syncytial Virus-associated hospitalization in premature infants who did not receive palivizumab prophylaxis in Italy: a retrospective analysis from the Osservatorio Study

BACKGROUND: Due to different social and epidemiological factors, the eligibility criteria to receive palivizumab prophylaxis may be different between countries, especially in “otherwise healthy” late preterm infants. METHODS: We analyzed an Italian database of young children referred to emergency de...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvestri, Michela, Marando, Francesca, Costanzo, Anna Maria, di Luzio Paparatti, Umberto, Rossi, Giovanni A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845497/
https://www.ncbi.nlm.nih.gov/pubmed/27112952
http://dx.doi.org/10.1186/s13052-016-0252-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845497/
https://www.ncbi.nlm.nih.gov/pubmed/27112952
http://dx.doi.org/10.1186/s13052-016-0252-9

Ejemplares similares